GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocugen Inc (FRA:2H51) » Definitions » EV-to-Revenue

Ocugen (FRA:2H51) EV-to-Revenue : 50.06 (As of May. 22, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Ocugen EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Ocugen's enterprise value is €209.45 Mil. Ocugen's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was €4.18 Mil. Therefore, Ocugen's EV-to-Revenue for today is 50.06.

The historical rank and industry rank for Ocugen's EV-to-Revenue or its related term are showing as below:

FRA:2H51' s EV-to-Revenue Range Over the Past 10 Years
Min: -2575.71   Med: 4650   Max: 53935.34
Current: 52.28

During the past 13 years, the highest EV-to-Revenue of Ocugen was 53935.34. The lowest was -2575.71. And the median was 4650.00.

FRA:2H51's EV-to-Revenue is ranked worse than
80.77% of 993 companies
in the Biotechnology industry
Industry Median: 7.17 vs FRA:2H51: 52.28

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-05-22), Ocugen's stock price is €0.7248. Ocugen's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was €0.02. Therefore, Ocugen's PS Ratio for today is 45.30.


Ocugen EV-to-Revenue Historical Data

The historical data trend for Ocugen's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocugen EV-to-Revenue Chart

Ocugen Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7,330.07 - 81.80 19.05 51.43

Ocugen Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.92 53.72 54.49 51.43 44.29

Competitive Comparison of Ocugen's EV-to-Revenue

For the Biotechnology subindustry, Ocugen's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ocugen's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ocugen's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Ocugen's EV-to-Revenue falls into.


;
;

Ocugen EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Ocugen's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=209.447/4.184
=50.06

Ocugen's current Enterprise Value is €209.45 Mil.
Ocugen's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.18 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ocugen  (FRA:2H51) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Ocugen's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=0.7248/0.016
=45.30

Ocugen's share price for today is €0.7248.
Ocugen's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ocugen EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ocugen's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Ocugen Business Description

Traded in Other Exchanges
Address
11 Great Valley Parkway, Malvern, PA, USA, 19355
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").

Ocugen Headlines

No Headlines